Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20064211HPVENSG00000147246.10protein_codingHTR2CNoNo3358P28335
TVIS20064150HPVENSG00000147246.10protein_codingHTR2CNoNo3358P28335
TVIS44027967HTLV-1ENSG00000147246.10protein_codingHTR2CNoNo3358P28335
TVIS44049811HTLV-1ENSG00000147246.10protein_codingHTR2CNoNo3358P28335
TVIS44035846HTLV-1ENSG00000147246.10protein_codingHTR2CNoNo3358P28335
TCGA Plot Options
Drug Information
GeneHTR2C
DrugBank IDDB09185
Drug NameViloxazine
Target IDBE0000533
UniProt IDP28335
Regulation Typeagonist
PubMed IDs32943948
CitationsYu C, Garcia-Olivares J, Candler S, Schwabe S, Maletic V: New Insights into the Mechanism of Action of Viloxazine: Serotonin and Norepinephrine Modulating Properties. J Exp Pharmacol. 2020 Aug 25;12:285-300. doi: 10.2147/JEP.S256586. eCollection 2020.
GroupsApproved; Investigational; Withdrawn
Direct ClassificationPhenol ethers
SMILESCCOC1=CC=CC=C1OCC1CNCCO1
Pathways
PharmGKB
ChEMBLCHEMBL306700